Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Merrills Cuts Vodafone; Liberum Cuts Glaxo

Thu, 30th Aug 2018 09:34

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:----------FTSE 100----------MERRILL LYNCH CUTS VODAFONE TO 'NEUTRAL' (BUY) - PRICE TARGET 202 (260) PENCE----------LIBERUM CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY')----------CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 6350 (5900) PENCE - 'OUTPERFORM'----------EXANE BNP CUTS BUNZL TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2425 PENCE ----------CREDIT SUISSE RAISES BUNZL PRICE TARGET TO 2600 (2470) PENCE - 'OUTPERFORM'----------BERENBERG RAISES PRUDENTIAL PRICE TARGET TO 2600 (2400) PENCE - 'BUY'----------DEUTSCHE BANK CUTS AB FOODS PRICE TARGET TO 3000 (3100) PENCE - 'BUY'----------DEUTSCHE BANK CUTS TAYLOR WIMPEY PRICE TARGET TO 237 (244) PENCE - 'BUY'----------DEUTSCHE BANK CUTS PERSIMMON PRICE TARGET TO 3053 (3093) PENCE - 'HOLD'----------DEUTSCHE BANK RAISES BERKELEY GROUP PRICE TARGET TO 4095 (4014) PENCE - 'HOLD'----------DEUTSCHE BANK CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 792 (794) PENCE - 'BUY'----------FTSE 250----------DEUTSCHE BANK RAISES BELLWAY TO 'BUY' ('HOLD') - TARGET 3745 (3716) PENCE----------RBC CUTS IWG TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 200 (220) PENCE----------MORGAN STANLEY RAISES UNITE GROUP TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - TARGET 930 (850) PENCE----------MORGAN STANLEY CUTS INTU PROPERTIES TO 'UNDERWEIGHT' (EQUAL-WEIGHT) - TARGET 150 (190) PENCE----------MORGAN STANLEY RAISES PETROFAC TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 800 (650) PENCE----------SOCGEN RAISES PETROFAC PRICE TARGET TO 791 (719) PENCE - 'BUY'----------KEPLER CHEUVREUX RAISES PETROFAC PRICE TARGET TO 700 (660) PENCE - 'HOLD' ----------LIBERUM RAISES HOMESERVE PRICE TARGET TO 1120 (950) PENCE - 'BUY'----------DEUTSCHE BANK CUTS REDROW PRICE TARGET TO 622 (672) PENCE - 'HOLD'----------DEUTSCHE BANK RAISES MCCARTHY & STONE PRICE TARGET TO 168 (165) PENCE - 'BUY'----------DEUTSCHE BANK CUTS CREST NICHOLSON PRICE TARGET TO 506 (524) PENCE - 'HOLD'----------RBC RAISES DIPLOMA PRICE TARGET TO 1280 (1130) PENCE - 'SECTOR PERFORM'----------OTHER MAIN MARKET AND AIM----------NUMIS RAISES FORTERRA TO 'BUY' ('ADD') - TARGET 365 PENCE----------NUMIS CUTS AMIGO HOLDINGS TO 'ADD' ('BUY') - TARGET 330 PENCE----------BERENBERG INITIATES SUMO GROUP WITH 'BUY' - TARGET 205 PENCE----------BERENBERG RAISES DALATA HOTEL PRICE TARGET TO 700 (660) PENCE - 'BUY'----------BERENBERG RAISES GYM GROUP PRICE TARGET TO 370 (320) PENCE - 'BUY'----------

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.